INHIBRx, Inc

Inhibrx is a clinical stage biotechnology company dedicated to
discovering and developing effective biologic therapeutics for people
with life-threatening conditions. Toward this goal, Inhibrx has
developed a diverse pipeline of therapeutic candidates specifically
designed to leverage the power of our proprietary single-domain
antibody platform and protein-engineering expertise.